KYMR icon

Kymera Therapeutics
KYMR

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$116
42% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
David Dai
0% 1-yr KYMR win rate
3 Mar ‘26 2 months ago
Citigroup
Citigroup
Geoff Meacham
33% 1-yr KYMR win rate
2 Mar ‘26 3 months ago
Stephens & Co
Stephens & Co
Sudan Loganathan
50% 1-yr KYMR win rate
2 Mar ‘26 3 months ago